Hepatitis B Virus X Protein Accelerates the Development of Hepatoma

Overview

Journal Cancer Biol Med

Specialty Oncology

Date 2014 Nov 4

PMID 25364579

Citations 54

Authors

Xiao-Dong Zhang

Yuan Wang

Li-Hong Ye

Affiliations

Soon will be listed here.

Abstract

The chronic infection of hepatitis B virus (HBV) is closely related to the occurrence and development of hepatocellular carcinoma (HCC). Accumulated evidence has shown that HBV X protein (HBx protein) is a multifunctional regulator with a crucial role in hepatocarcinogenesis. However, information on the mechanism by which HBV induces HCC is lacking. This review focuses on the pathological functions of HBx in HBV-induced hepatocarcinogenesis. As a transactivator, HBx can modulate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and transcription factor AP-2. Moreover, HBx can affect regulatory non-coding RNAs (ncRNAs) including microRNAs and long ncRNAs (lncRNAs), such as miRNA-205 and highly upregulated in liver cancer (HULC), respectively. HBx is also involved in epigenetic modification, including methylation and acetylation. HBx interacts with various signal-transduction pathways, such as protein kinase B/Akt, Wnt/β-catenin, signal transducer and activator of transcription, and NF-κB pathways. Moreover, HBx affects cellular fate by shifting the balance toward cell survival. HBx may lead to the loss of apoptotic functions or directly contributes to oncogenesis by achieving transforming functions, which induce hepatocarcinogenesis. Additionally, HBx can modulate apoptosis and immune response by direct or indirect interaction with host factors. We conclude that HBx hastens the development of hepatoma.

Citing Articles

State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

Giron-Michel J, Padelli M, Oberlin E, Guenou H, Duclos-Vallee J BioDrugs. 2025; 39(2):237-260.

PMID: 39826071 PMC: 11906529. DOI: 10.1007/s40259-024-00702-0.

Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein.

Li X, Kong D, Hu W, Zheng K, You H, Tang R Infect Agent Cancer. 2024; 19(1):56.

PMID: 39529119 PMC: 11555838. DOI: 10.1186/s13027-024-00618-y.

Regulatory role of microRNAs in virus-mediated inflammation.

Baghi H, Bayat M, Mehrasa P, Alavi S, Lotfalizadeh M, Memar M J Inflamm (Lond). 2024; 21(1):43.

PMID: 39497125 PMC: 11536602. DOI: 10.1186/s12950-024-00417-7.

Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma.

Xu L, Xu Y, Zhang F, Xu P, Wang L Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(1):64-72.

PMID: 38426692 PMC: 10945487. DOI: 10.3724/zdxbyxb-2023-0481.

Arginine methylation of HSPA8 by PRMT9 inhibits ferroptosis to accelerate hepatitis B virus-associated hepatocellular carcinoma progression.

Deng W, Ai J, Zhang W, Zhou Z, Li M, Yan L J Transl Med. 2023; 21(1):625.

PMID: 37715221 PMC: 10503172. DOI: 10.1186/s12967-023-04408-9.

References

Hu L, Chen L, Yang G, Li L, Sun H, Chang Y . HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol Cancer. 2011; 10:43. PMC: 3096594. DOI: 10.1186/1476-4598-10-43. View

Sun Q, Wang R, Wang Y, Luo J, Wang P, Cheng B . Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma. Oncol Rep. 2013; 31(2):933-9. DOI: 10.3892/or.2013.2917. View

Arzumanyan A, Friedman T, Kotei E, Ng I, Lian Z, Feitelson M . Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene. 2011; 31(5):563-72. PMC: 3183380. DOI: 10.1038/onc.2011.255. View

Seeger C, Mason W . Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000; 64(1):51-68. PMC: 98986. DOI: 10.1128/MMBR.64.1.51-68.2000. View

Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z . Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 2013; 25(5):1037-43. DOI: 10.1016/j.cellsig.2013.01.019. View

Teng J, Wang X, Xu Z, Tang N . HBx-dependent activation of Twist mediates STAT3 control of epithelium-mesenchymal transition of liver cells. J Cell Biochem. 2012; 114(5):1097-104. DOI: 10.1002/jcb.24450. View

Yang B, Bouchard M . The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol. 2011; 86(1):313-27. PMC: 3255901. DOI: 10.1128/JVI.06442-11. View

Zhang X, You X, Li N, Zhang W, Gagos S, Wang Q . Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA. FEBS Lett. 2012; 586(19):3215-21. DOI: 10.1016/j.febslet.2012.06.039. View

Zhang X, Zhang H, Ye L . Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med. 2006; 147(2):58-66. DOI: 10.1016/j.lab.2005.10.003. View

10.

Seto E, Mitchell P, Yen T . Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature. 1990; 344(6261):72-4. DOI: 10.1038/344072a0. View

11.

Shukla R, Yue J, Siouda M, Gheit T, Hantz O, Merle P . Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling. Carcinogenesis. 2011; 32(7):978-85. DOI: 10.1093/carcin/bgr057. View

12.

Wu B, Li C, Chen H, Chang J, Jeng K, Chou C . Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun. 2006; 340(3):916-28. DOI: 10.1016/j.bbrc.2005.12.089. View

13.

Kew M . Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol. 2011; 26 Suppl 1:144-52. DOI: 10.1111/j.1440-1746.2010.06546.x. View

14.

Lee W, Lan K, Li C, Chao Y, Lin H, Lee S . Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt. Arch Biochem Biophys. 2012; 528(2):156-62. DOI: 10.1016/j.abb.2012.08.008. View

15.

Damania P, Sen B, Dar S, Kumar S, Kumari A, Gupta E . Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One. 2014; 9(3):e91745. PMC: 3954734. DOI: 10.1371/journal.pone.0091745. View

16.

Huang J, Guo Y, Zhao C, Yuan S, Wang Y, Tang G . Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology. 2012; 57(5):1882-92. DOI: 10.1002/hep.26195. View

17.

Ng R, Lau C, Lee S, Tsui S, Fung K, Waye M . cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem Biophys Res Commun. 2004; 322(3):827-35. DOI: 10.1016/j.bbrc.2004.07.188. View

18.

Waris G, Huh K, Siddiqui A . Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol. 2001; 21(22):7721-30. PMC: 99943. DOI: 10.1128/MCB.21.22.7721-7730.2001. View

19.

Gao B, Wang H, Lafdil F, Feng D . STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol. 2012; 57(2):430-41. PMC: 3399024. DOI: 10.1016/j.jhep.2012.01.029. View

20.

Han Q, Zhang C, Zhang J, Tian Z . Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition. PLoS One. 2011; 6(12):e27931. PMC: 3234243. DOI: 10.1371/journal.pone.0027931. View